These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8889914)

  • 1. Cognitive effects of flumazenil in patients with Alzheimer's disease.
    Ott BR; Thompson JA; Whelihan WM
    J Clin Psychopharmacol; 1996 Oct; 16(5):400-2. PubMed ID: 8889914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flumazenil administration attenuates cognitive impairment in immature rats after controlled cortical impact.
    Ochalski PG; Fellows-Mayle W; Hsieh LB; Srinivas R; Okonkwo DO; Dixon CE; Adelson PD
    J Neurotrauma; 2010 Mar; 27(3):647-51. PubMed ID: 19929186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alzheimer's disease--treatment with and without drugs].
    Wolter DK
    MMW Fortschr Med; 2012 Apr; 154(7):85-7, 89-90. PubMed ID: 22558882
    [No Abstract]   [Full Text] [Related]  

  • 4. Measuring cognitive change in Alzheimer's disease clinical drug trials.
    Harrison JE
    J Nutr Health Aging; 2007; 11(4):327-9. PubMed ID: 17653492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam for agitated Alzheimer's disease patients.
    Weiner MF; Womack KB; Martin-Cook K; Svetlik DA; Hynan LS
    Int Psychogeriatr; 2005 Jun; 17(2):327-8. PubMed ID: 16050441
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of donepezil on Alzheimer's disease: the relationship between cognitive function and rapid eye movement sleep.
    Mizuno S; Kameda A; Inagaki T; Horiguchi J
    Psychiatry Clin Neurosci; 2004 Dec; 58(6):660-5. PubMed ID: 15601392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Idiopathic and recurrent stupor: efficacy of flumazenil].
    Lemesle M; Aube H; Madinier G; Manceau E; Wilkening M; Giroud M
    Presse Med; 1996 Nov; 25(37):1847. PubMed ID: 8991042
    [No Abstract]   [Full Text] [Related]  

  • 8. Psychometric evaluation of ADAS-Cog and NTB for measuring drug response.
    Karin A; Hannesdottir K; Jaeger J; Annas P; Segerdahl M; Karlsson P; Sjögren N; von Rosen T; Miller F
    Acta Neurol Scand; 2014 Feb; 129(2):114-22. PubMed ID: 23763450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study.
    Gareri P; Castagna A; Cotroneo AM; Putignano D; Conforti R; Santamaria F; Marino S; Putignano S
    J Alzheimers Dis; 2017; 56(2):557-565. PubMed ID: 28035929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease.
    Rockwood K; Fay S; Gorman M
    Int J Geriatr Psychiatry; 2010 Feb; 25(2):191-201. PubMed ID: 19548273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial cognitive response to cholinesterase inhibitors and subsequent long-term course in patients with mild Alzheimer's disease.
    Droogsma E; van Asselt D; Diekhuis M; Veeger N; van der Hooft C; De Deyn PP
    Int Psychogeriatr; 2015 Aug; 27(8):1323-33. PubMed ID: 25779465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of flumazenil on sleepiness, task performance and nocturnal sleep after anesthesia with midazolam.
    Ozone M; Itoh H; Ohbuchi K; Ohyama E; Hayashida K; Sato M; Sasaki M; Ushijima S; Tanifuji Y
    Psychiatry Clin Neurosci; 2001 Jun; 55(3):235-7. PubMed ID: 11422855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does midazolam cause retrograde amnesia, and can flumazenil reverse that amnesia?
    Koht A; Moss JI
    Anesth Analg; 1997 Jul; 85(1):211-2. PubMed ID: 9212149
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of donepezil in patients with Alzheimer's disease: results of a global, multinational, clinical experience study.
    Boada-Rovira M; Brodaty H; Cras P; Baloyannis S; Emre M; Zhang R; Bahra R;
    Drugs Aging; 2004; 21(1):43-53. PubMed ID: 14715043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of Life and Utility Measurement in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer's Disease: Determinants and Level of Changes Observed.
    Lacey L; Bobula J; Rüdell K; Alvir J; Leibman C
    Value Health; 2015 Jul; 18(5):638-45. PubMed ID: 26297092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease.
    Johannsen P; Salmon E; Hampel H; Xu Y; Richardson S; Qvitzau S; Schindler R;
    CNS Drugs; 2006; 20(4):311-25. PubMed ID: 16599649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic hepatic encephalopathy treated by long-term intravenous administration of flumazenil in ambulatory care].
    Péroux JL; Paolini O; Tran A; Frappa B; Rampal P
    Gastroenterol Clin Biol; 1996 Feb; 20(1):106-8. PubMed ID: 8734316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of responders and non-responders to long-term donepezil treatment.
    Inoue J; Hoshino R; Nojima H; Ishida W; Okamoto N
    Psychogeriatrics; 2010 Jun; 10(2):53-61. PubMed ID: 20738808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong.
    Chu LW; Yik PY; Mok W; Chung CP
    Int J Clin Pract; 2007 Mar; 61(3):403-10. PubMed ID: 17313606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of a paradoxical reaction to midazolam with flumazenil.
    Thurston TA; Williams CG; Foshee SL
    Anesth Analg; 1996 Jul; 83(1):192. PubMed ID: 8659737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.